Spero Therapeutics, Inc.
SPRO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$68,566 | $22,806 | -$46,415 | -$89,756 |
| Dep. & Amort. | $2 | $367 | $1,547 | $1,117 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $7,793 | $7,932 | $0 | $0 |
| Change in WC | $36,284 | -$70,375 | $22,087 | $12,862 |
| Other Non-Cash | $1,043 | $6,275 | $15,050 | $11,430 |
| Operating Cash Flow | -$23,444 | -$32,995 | -$7,731 | -$64,347 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $39 |
| Inv. Purchases | $0 | $0 | -$26,970 | -$43,915 |
| Inv. Sales/Matur. | $0 | $0 | $60,777 | $51,548 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $33,807 | $7,672 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | -$54,485 | $47,480 |
| Stock Issued | $0 | $221 | $24,932 | $36,570 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $0 | $221 | -$29,553 | $84,050 |
| Forex Effect | $0 | $0 | $0 | -$0 |
| Net Chg. in Cash | -$23,444 | -$32,774 | -$3,477 | $27,375 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $76,333 | $109,107 | $112,584 | $85,209 |
| End Cash | $52,889 | $76,333 | $109,107 | $112,584 |
| Free Cash Flow | -$23,444 | -$32,995 | -$7,731 | $0 |